AI in Medicine News ・ ⚖️ Device approvals and regulation

FDA's AI in Early Phase Clinical Trials RFI: An Opportunity to Help Set the Rules of the Road

Crowell & Moring LLP · 11/06 07:03 UTC

The FDA has issued a Request for Information (RFI) seeking input on AI in early-phase clinical trials. The RFI is consistent with recent FDA initiatives on leveraging AI technologies and improving early-phase clinical trial conduct.

Read the original (Crowell & Moring LLP)

See it in the digest → ・ See this issue →